CoChat

Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide

Open access
Tourkina, Elena, Bonner, Michael, Oates, James, Hofbauer, Ann, Richard, Mathieu, Znoyko, Sergei, Visconti, Richard P, Zhang, Jing, Hatfield, Corey M, Silver, Richard M, Hoffman, Stanley · 2011 · Fibrogenesis & Tissue Repair

The DOI matches its Crossref record; 30 of the 32 references it cites were found in a registry or an index.

Abstract

Interstitial lung disease (ILD) is a major cause of morbidity and mortality in scleroderma (systemic sclerosis, or SSc). Fibrocytes are a monocyte-derived cell population implicated in the pathogenesis of fibrosing disorders. Given the recently recognized importance of caveolin-1 in regulating function and signaling in SSc monocytes, in the present study we examined the role of caveolin-1 in the migration and/or trafficking and phenotype of monocytes and fibrocytes in fibrotic lung disease in human patients and an animal model. These studies fill a gap in our understanding of how monocytes and fibrocytes contribute to SSc-ILD pathology. We found that C-X-C chemokine receptor type 4-positive (CXCR4+)/collagen I-positive (ColI+), CD34+/ColI+ and CD45+/ColI+ cells are present in SSc-ILD lungs, but not in control lungs, with CXCR4+ cells being most prevalent. Expression of CXCR4 and its ligand, stromal cell-derived factor 1 (CXCL12), are also highly upregulated in SSc-ILD lung tissue. SSc monocytes, which lack caveolin-1 and therefore overexpress CXCR4, exhibit almost sevenfold increased migration toward CXCL12 compared to control monocytes. Restoration of caveolin-1 function by administering the caveolin scaffolding domain (CSD) peptide reverses this hypermigration. Similarly, transforming growth factor β-treated normal monocytes lose caveolin-1, overexpress CXCR4 and exhibit 15-fold increased monocyte migration that is CSD peptide-sensitive. SSc monocytes exhibit a different phenotype than normal monocytes, expressing high levels of ColI, CD14 and CD34. Because ColI+/CD14+ cells are prevalent in SSc blood, we looked for such cells in lung tissue and confirmed their presence in SSc-ILD lungs but not in normal lungs. Finally, in the bleomycin model of lung fibrosis, we show that CSD peptide diminishes fibrocyte accumulation in the lungs. Our results suggest that low caveolin-1 in SSc monocytes contributes to ILD via effects on cell migration and phenotype and that the hyperaccumulation of fibrocytes in SSc-ILD may result from the altered phenotype and migratory activity of their monocyte precursors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1755-1536-4-15

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Fibrocyte subsets in lung tissue of patients with systemic sclerosis-interstitial lung disease. Fixed, paraffin-embedded lung tissue sections from normal adults and adults with systemic sclerosis-interstitial lung disease (SSc-ILD) were stained for CD34, CD45, C-X-C chemokine receptor type 4 (CXCR4) and collagen I (ColI). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) (blue). Left: low-magnification images. Right: high-magnification images. The portion of the low-magnification image that is presented at high magnification is boxed. (A) CXCR4 (red)/ColI (green). (B) CD45 (red)/ColI (green). (C) CD34 (red)/ColI (green). (D) The number of double-labeled cells per field was determined from images of sections obtained from seven SSc-ILD patients and four normal subjects, with six randomly chosen fields per sectio. *P < 0.05. CXCR4 expression was evaluated by performing Western blot analysis on extracts of three normal lung samples and four SSc-ILD lung samples (E) and then quantifying them densitometrically (F) using actin as a loading control. Bars = 10 μm.
Figure 1 Fibrocyte subsets in lung tissue of patients with systemic sclerosis-interstitial lung disease. Fixed, paraffin-embedded lung tissue sections from normal adults and adults with systemic sclerosis-interstitial lung disease (SSc-ILD) were stained for CD34, CD45, C-X-C chemokine receptor type 4 (CXCR4) and collagen I (ColI). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI) (blue). Left: low-magnification images. Right: high-magnification images. The portion of the low-magnification image that is presented at high magnification is boxed. (A) CXCR4 (red)/ColI (green). (B) CD45 (red)/ColI (green). (C) CD34 (red)/ColI (green). (D) The number of double-labeled cells per field was determined from images of sections obtained from seven SSc-ILD patients and four normal subjects, with six randomly chosen fields per sectio. *P < 0.05. CXCR4 expression was evaluated by performing Western blot analysis on extracts of three normal lung samples and four SSc-ILD lung samples (E) and then quantifying them densitometrically (F) using actin as a loading control. Bars = 10 μm.CC BY · PubMed Central
Figure 2 Stromal cell-derived factor 1 in human lung tissue. Tissue sections of normal and SSc-ILD lungs were stained with anti-stromal cell-derived factor 1 (anti-CXCL12) (red) and the nuclear stain DAPI (blue). (A) Normal lung tissue section at × 10 magnification. (B) SSc-ILD lung tissue section at × 10 magnification. (C) SSc-ILD lung tissue section at × 20 magnification. (D) SSc-ILD lung tissue section at × 20 magnification without primary antibody control. Note the massive CXCL12 staining in SSc-ILD lung tissue (B) and (C) and little staining in normal lung tissue (A). e, epithelial cells; M, macrophage. Bars = 10 μm.
Figure 2 Stromal cell-derived factor 1 in human lung tissue. Tissue sections of normal and SSc-ILD lungs were stained with anti-stromal cell-derived factor 1 (anti-CXCL12) (red) and the nuclear stain DAPI (blue). (A) Normal lung tissue section at × 10 magnification. (B) SSc-ILD lung tissue section at × 10 magnification. (C) SSc-ILD lung tissue section at × 20 magnification. (D) SSc-ILD lung tissue section at × 20 magnification without primary antibody control. Note the massive CXCL12 staining in SSc-ILD lung tissue (B) and (C) and little staining in normal lung tissue (A). e, epithelial cells; M, macrophage. Bars = 10 μm.CC BY · PubMed Central
Figure 3 Fibrocyte subsets in the peripheral blood of SSc-ILD patients and normal subjects. Human peripheral blood mononuclear cells (PBMCs) were isolated and analyzed by flow cytometry for CD45, CXCR4 and ColI. Seven patients and seven normal subjects were used in these studies. (A) Note that the number of CD45+/ColI+ and CXCR+/ColI+ cells is higher in SSc-ILD blood than in normal blood. Note that CD45+/ColI+ fibrocytes are much more prevalent than CXCR4+/ColI+ cells. **P < 0.01. *P < 0.05. (B) and (C) Primary data demonstrating that fluorescence levels provided by isotype controls are readily distinguished from fluorescence levels provided by specific antibodies. For FL1 fluorescence, primary antibodies are biotinylated isotype controls (B) and biotinylated rabbit anti-ColI (C). For FL2 fluorescence, antibodies are isotype control phycoerythrin (PE) (B) and anti-CD45 PE monoclonal antibody (C).
Figure 3 Fibrocyte subsets in the peripheral blood of SSc-ILD patients and normal subjects. Human peripheral blood mononuclear cells (PBMCs) were isolated and analyzed by flow cytometry for CD45, CXCR4 and ColI. Seven patients and seven normal subjects were used in these studies. (A) Note that the number of CD45+/ColI+ and CXCR+/ColI+ cells is higher in SSc-ILD blood than in normal blood. Note that CD45+/ColI+ fibrocytes are much more prevalent than CXCR4+/ColI+ cells. **P < 0.01. *P < 0.05. (B) and (C) Primary data demonstrating that fluorescence levels provided by isotype controls are readily distinguished from fluorescence levels provided by specific antibodies. For FL1 fluorescence, primary antibodies are biotinylated isotype controls (B) and biotinylated rabbit anti-ColI (C). For FL2 fluorescence, antibodies are isotype control phycoerythrin (PE) (B) and anti-CD45 PE monoclonal antibody (C).CC BY · PubMed Central
Figure 4 Monocyte migration in vitro. The migration of normal and SSc-ILD monocytes toward CXCL12, the effect of TGFβ on normal monocyte migration and the ability of caveolin scaffolding domain (CSD) peptide to inhibit migration were quantified as described in Materials and methods. Each symbol represents the results obtained with cells from a different donor. The median value obtained in each category is indicated by a line. (A) Normal versus SSC-ILD ± CSD. Each symbol represents one subject. Note the almost sevenfold increase in migration in SSc-ILD lung tissue and the almost complete inhibition of migration by CSD peptide. (B) Normal ± transforming growth factor β (TGFβ) ± CSD. Each symbol represents one subject. Note the 15-fold increase in migration induced by TGFβ and the almost complete inhibition of migration by CSD peptide.
Figure 4 Monocyte migration in vitro. The migration of normal and SSc-ILD monocytes toward CXCL12, the effect of TGFβ on normal monocyte migration and the ability of caveolin scaffolding domain (CSD) peptide to inhibit migration were quantified as described in Materials and methods. Each symbol represents the results obtained with cells from a different donor. The median value obtained in each category is indicated by a line. (A) Normal versus SSC-ILD ± CSD. Each symbol represents one subject. Note the almost sevenfold increase in migration in SSc-ILD lung tissue and the almost complete inhibition of migration by CSD peptide. (B) Normal ± transforming growth factor β (TGFβ) ± CSD. Each symbol represents one subject. Note the 15-fold increase in migration induced by TGFβ and the almost complete inhibition of migration by CSD peptide.CC BY · PubMed Central
Figure 5 Phenotype of SSc-ILD and normal monocytes. PBMCs were isolated and analyzed by using flow cytometry as indicated for their expression of ColI, CD11b, CD14 and CD34. Each symbol represents the results obtained with cells from a different donor. The median value obtained in each category for SSc-ILD patients and normal donors is indicated by a line. (A) Double-labeled analysis. Note that among CD11b+ monocytes, CD14+ cells are more prevalent among SSc-ILD cells than among normal cells. (B) Triple- and quadruple-labeled analyses. Note that CD14+/ColI+, CD14+/CD34+/ColI+, and CD14-/CD34+/ColI+ cells are more prevalent among SSc-ILD CD11b+ monocytes than among normal CD11b+ monocytes. *P < 0.05.
Figure 5 Phenotype of SSc-ILD and normal monocytes. PBMCs were isolated and analyzed by using flow cytometry as indicated for their expression of ColI, CD11b, CD14 and CD34. Each symbol represents the results obtained with cells from a different donor. The median value obtained in each category for SSc-ILD patients and normal donors is indicated by a line. (A) Double-labeled analysis. Note that among CD11b+ monocytes, CD14+ cells are more prevalent among SSc-ILD cells than among normal cells. (B) Triple- and quadruple-labeled analyses. Note that CD14+/ColI+, CD14+/CD34+/ColI+, and CD14-/CD34+/ColI+ cells are more prevalent among SSc-ILD CD11b+ monocytes than among normal CD11b+ monocytes. *P < 0.05.CC BY · PubMed Central
Figure 6 CD14+/ColI+ cells are present in SSc-ILD lung tissue. Fixed, paraffin-embedded adult lung tissue sections from normal and SSc-ILD subjects were stained for CD14 and ColI. Nuclei were stained with DAPI (blue). Top: low-magnification images showing SSc-ILD adult lung tissue. Bottom: high-magnification images showing SSc-ILD adult lung tissue. The portion of the low-magnification image presented at high magnification is boxed. ColI, green; CD14, red. Note that CD14+/ColI+ cells are present in SSc-ILD lung tissue, but not in normal lung tissue. Bar = 10 μm.
Figure 6 CD14+/ColI+ cells are present in SSc-ILD lung tissue. Fixed, paraffin-embedded adult lung tissue sections from normal and SSc-ILD subjects were stained for CD14 and ColI. Nuclei were stained with DAPI (blue). Top: low-magnification images showing SSc-ILD adult lung tissue. Bottom: high-magnification images showing SSc-ILD adult lung tissue. The portion of the low-magnification image presented at high magnification is boxed. ColI, green; CD14, red. Note that CD14+/ColI+ cells are present in SSc-ILD lung tissue, but not in normal lung tissue. Bar = 10 μm.CC BY · PubMed Central
Figure 7 Flow cytometric quantification of CD45+/CXCR4+/ColI+ fibrocytes in mouse lung tissue. Total lung cells were isolated from mice (three to six mice in each category) ten days after saline or bleomycin treatment. The mice had been treated daily with CSD or control peptide starting one day prior to saline or bleomycin treatment. CD45+/CXCR4high/ColI+ fibrocytes were quantified by performing flow cytometry. (A) Results from a typical experiment in which lung cells from the indicated individual mice were gated based on CD45 staining, then resolved on two-dimensional scatterplots based on their ColI and CXCR4 staining. Vertical and horizontal bars delimit the zone in which cells stained with isotype controls are found. We refer to the cells that are slightly into the upper right quadrant as CXCR4low, and we refer to cells within the box as CXCR4high. Therefore, the square box contains cells that are CD45+/CXCR4high/ColI+. (B) The percentage of cells falling within the square box is presented for each category of mice. The data represent the average of from three to six mice in each category ± standard error of the mean. **P < 0.01. *P < 0.05.
Figure 7 Flow cytometric quantification of CD45+/CXCR4+/ColI+ fibrocytes in mouse lung tissue. Total lung cells were isolated from mice (three to six mice in each category) ten days after saline or bleomycin treatment. The mice had been treated daily with CSD or control peptide starting one day prior to saline or bleomycin treatment. CD45+/CXCR4high/ColI+ fibrocytes were quantified by performing flow cytometry. (A) Results from a typical experiment in which lung cells from the indicated individual mice were gated based on CD45 staining, then resolved on two-dimensional scatterplots based on their ColI and CXCR4 staining. Vertical and horizontal bars delimit the zone in which cells stained with isotype controls are found. We refer to the cells that are slightly into the upper right quadrant as CXCR4low, and we refer to cells within the box as CXCR4high. Therefore, the square box contains cells that are CD45+/CXCR4high/ColI+. (B) The percentage of cells falling within the square box is presented for each category of mice. The data represent the average of from three to six mice in each category ± standard error of the mean. **P < 0.01. *P < 0.05.CC BY · PubMed Central
Figure 8 CSD peptide inhibits the bleomycin-induced accumulation of CD45+/ColI+ fibrocytes in lung tissue. Sections from saline-treated mice receiving the CSD peptide (CSD) or the control, scrambled peptide (Control) and sections from bleomycin-treated mice receiving the CSD peptide (Bleo/CSD) or the scrambled peptide (Bleo) were harvested ten days after treatment, then stained for CD45 (green) and ColI (red). Nuclei were labeled with DAPI (blue). (A) Upper row: merged low-magnification images. Lower row: merged high-magnification images. Bars = 10 μm. (B) The average number of CD45+/ColI+ fibrocytes per field was determined in images from six mice in each category, with five fields per mouse. **P < 0.01. *P < 0.05.
Figure 8 CSD peptide inhibits the bleomycin-induced accumulation of CD45+/ColI+ fibrocytes in lung tissue. Sections from saline-treated mice receiving the CSD peptide (CSD) or the control, scrambled peptide (Control) and sections from bleomycin-treated mice receiving the CSD peptide (Bleo/CSD) or the scrambled peptide (Bleo) were harvested ten days after treatment, then stained for CD45 (green) and ColI (red). Nuclei were labeled with DAPI (blue). (A) Upper row: merged low-magnification images. Lower row: merged high-magnification images. Bars = 10 μm. (B) The average number of CD45+/ColI+ fibrocytes per field was determined in images from six mice in each category, with five fields per mouse. **P < 0.01. *P < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 3

  1. Metchnikov II: Immunity of Infectious Diseases. 1901, Paris, France. Masson
  2. Maximow AA: Cultures of blood leucocytes: from lymphocyte and monocyte to connective tissue. Arch Exp Zellforsch. 1928, 5: 169-268.
  3. Fischer AC: Transformation outside of organism of mononuclears into fibroblasts. Compt Rend Soc Biol. 1925, 92: 109-112.

Cited by

See all 107

Metadata

Authors
Tourkina, E., Bonner, M., Oates, J., Hofbauer, A., Richard, M., Znoyko, S., Visconti, R. P., Zhang, J., Hatfield, C. M., Silver, R. M., & Hoffman, S.
Affiliations
Medical University of South Carolina (US)
Corresponding author
Tourkina, Elena
Venue
Fibrogenesis & Tissue Repair
Published
2011-07-01
Volume
4
Issue
1
Pages
15-15
ISSN
1755-1536 (ISSN-L)
OpenAlex
W2016100345
Cited by
104
References
32
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 11 · 2016: 8 · 2015: 4 · 2014: 9 · 2013: 12 · 2012: 15
FWCI
8.53
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Fibrogenesis & Tissue Repair (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Yale University
  • Medical University of South Carolina (C06 RR015455)
  • University of South Carolina
  • Fondation Leducq
  • National Institutes of Health (1c06rr015455-01a1, RR-016434, AR049459)
  • National Center for Complementary and Alternative Medicine
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR062078, P60AR049459, P60AR062755)
  • National Center for Research Resources (UL1RR029882, P20RR021949, C06 RR-015455)
  • National Center for Complementary and Integrative Health (R21AT004450)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
systemic sclerosis, interstitial lung disease, caveolin-1, monocytes, fibrocytes, CXCR4, CXCL12, monocyte migration, pulmonary fibrosis, bleomycin-induced lung fibrosis, type I collagen, TGF-beta, CD14, CD34

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. https://app.cochat.ai/papers/10.1186/1755-1536-4-15
The paper
Tourkina, E., Bonner, M., Oates, J., Hofbauer, A., Richard, M., Znoyko, S., Visconti, R. P., Zhang, J., Hatfield, C. M., Silver, R. M., & Hoffman, S. (2011). Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis & Tissue Repair. https://doi.org/10.1186/1755-1536-4-15

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.